Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG)

• Julia Kostka ,

  Contributed equally to this work with: Julia Kostka, Anu S. Maharjan

  Roles Investigation, Writing – original draft

  * E-mail: kostka@uchc.edu

  Affiliation Infectious Disease, UConn Health, Farmington, Connecticut, United States of America

  https://orcid.org/0000-0002-8347-4900

  ⨯
• Anu S. Maharjan ,

  Contributed equally to this work with: Julia Kostka, Anu S. Maharjan

  Roles Investigation, Writing – original draft

  Affiliation Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, United States of America

  ⨯
• Sanjai Kumar,

  Roles Investigation, Writing – review & editing

  Affiliation Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Douglas Hackenyos,

  Roles Resources, Writing – review & editing

  Affiliation Pharmacy, UConn Health, Farmington, Connecticut, United States of America

  ⨯
• Peter J. Krause ,

  Roles Conceptualization, Resources, Writing – review & editing

  ¶‡ These authors are co-last authors on this work.

  Affiliation Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Kevin Dieckhaus

  Roles Conceptualization, Resources, Writing – review & editing

  ¶‡ These authors are co-last authors on this work.

  Affiliation Infectious Disease, UConn Health, Farmington, Connecticut, United States of America

  ⨯